Ketamine Provided Short-Term Pain Relief in Meta-Analysis
A systematic review of 15 clinical trials showed ketamine effectively reduced refractory neuropathic pain.
Updated on Oct. 13, 2026 in Substance Abuse
Live Poll
Would you choose a treatment with known side-effect risks for short-term pain relief?
A meta-analysis published on August 11, 2026, found that intravenous ketamine treatment offers short-term relief for patients suffering from refractory neuropathic pain. The review utilized data from 15 clinical trials involving 251 patients to assess the efficacy and safety of the drug.
Why it matters
The study suggests that ketamine could serve as a valuable tool for patients who do not respond to traditional pain treatments due to its ability to modulate central sensitization. However, the higher incidence of side effects compared to placebos requires careful consideration of the drug's safety profile.
The meta-analysis reviewed 15 clinical trials featuring 251 patients, with ketamine recipients showing a 2.79 relative risk for a 50% reduction in pain. Researchers identified a 3.27 relative risk of adverse events among those treated with intravenous ketamine.
The details
Researchers conducted a systematic review comparing intravenous ketamine at doses ranging from 60 µg/kg to 1 mg/kg against placebos. The study excluded one trial deemed to have a high risk of bias to ensure the integrity of the findings regarding pain modulation.
Timeline
March 2026 was the final month researchers searched study databases.
The findings were originally published on August 11, 2026.
The Big Picture
This meta-analysis extends the clinical study of central sensitization mechanisms by providing quantifiable relative risk data for analgesic interventions.
Patients dealing with chronic neuropathic pain may see ketamine presented as a new option by their physicians for short-term symptom management. Individuals should discuss the significantly higher risk of adverse events with their doctors before considering this treatment.
The takeaway
While ketamine demonstrates promise for acute pain relief, the increased likelihood of adverse events necessitates a rigorous assessment of medical history. Patients are encouraged to consult specialists to determine if the potential benefits outweigh the side effects in their specific case.
Further reading
For more information on clinical research, visit the Substance Abuse section.
Live Poll
Would you choose a treatment with known side-effect risks for short-term pain relief?
